Directed Orchestration of Microfluidic Environments for guided Self-organisation

The project develops the DOMES microfluidic platform to study environmental impacts on kidney organogenesis, enhancing understanding of congenital anomalies through advanced 3D cell culture models.

Subsidie
€ 150.000
2022

Projectdetails

Introduction

In Europe, 263 per 10,000 pregnancies are diagnosed with a fetal congenital anomaly. Congenital anomalies, also referred to as birth defects, are defined as structural or functional disorders that occur during fetal development and are inherited, and/or caused by environmental factors.

Problem Statement

Unfortunately, the link between environmental factors, such as drugs, toxins, or other chemicals, and the manifestation of these multifactorial disorders is poorly understood. To identify environmental factors affecting tissue and organogenesis and study their pathogenic mechanisms, new 3D in vitro models with reliable and highly reproducible architecture are urgently needed.

Current Limitations

None of the current cell culture systems available can provide the controlled environment needed to sufficiently guide the self-organization process of stem cell-based 3D in vitro models.

Solution: DOMES Platform

Our new microfluidic platform, DOMES, is the first of its kind, combining precise control over morphogenetic processes with standardized and user-friendly handling. In this project, we will exemplarily focus on congenital diseases of the kidney, in particular the collecting duct system.

Research Focus

We will analyze on-chip the impact of specific environmental compounds, such as drugs and endocrine disruptors, on the branching morphogenesis of the collecting duct.

Broader Applications

DOMES is a product family of microfluidic 3D cell culture chips which will allow the control and study not only of kidney organoids, but of other 3D cell models including:

  • Lung organoids
  • Neural organoids
  • Gut organoids
  • Embryoid bodies

This is the first instance of a cell culture platform allowing direct orchestration of the microfluidic environment for guiding self-organization, symmetry breaking, and organogenesis. It represents a paradigm shift in researchers' ability to study the development of organs and their congenital anomalies in vitro.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-6-2022
Einddatum30-11-2023
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • UNIVERSITEIT MAASTRICHTpenvoerder

Land(en)

Geen landeninformatie beschikbaar

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Engineering the Origin of Human Shape: Defining Patterns and Axes in the Early Stage of 3D Pluripotency

OriSha aims to revolutionize in vitro human embryonic development modeling by using a hydrogel-microfluidic system to control biochemical signals for studying neural tube morphogenesis.

€ 1.499.633
ERC Proof of...

High Throughput Modelling and Measurement of Human Epithelial Models using Electrospun Conducting Polymers For Unlocking Data-Driven Drug Discovery

The project aims to enhance drug discovery by developing simplified Organ on Chip platforms through hydrogel electrospinning, enabling scalable monitoring and integration into industry workflows.

€ 150.000
ERC Starting...

Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular Disease

The 3DVasCMD project aims to develop a 3D vascularized cardiac model using iPSC technology to study coronary microvascular disease and identify therapeutic targets for improved cardiovascular health.

€ 1.496.395
ERC Proof of...

Advanced 3D in vitro models based on magnetically-driven docking of modular microscaffolds

This project aims to develop 3D modular co-culture systems using magnetic microscaffolds to replicate brain tumor microenvironments for drug screening and cancer therapy testing.

€ 150.000
ERC Starting...

Feedback-control of the Microenvironment: Modular Organ-on-Chip Technology to elucidate the role of Neurovascular Stress in Schizophrenia

CHIPzophrenia aims to develop a feedback-controlled organ-on-chip system to study nitrosative stress effects on the blood-brain barrier, enhancing in-vitro research for schizophrenia and related disorders.

€ 1.499.375

Vergelijkbare projecten uit andere regelingen

EIC Accelerator

Multi-organ toxicity and efficacy test platform for Personalized medicine & Drug development

Cherry Biotech aims to revolutionize drug development and personalized medicine by providing a patented 3D cell culture platform that enhances predictability and reduces reliance on animal testing.

€ 2.499.831
EIC Transition

IDEFIX Multiorgan toxicity and efficacy test platform

Cherry Biotech's IDEFIX project aims to revolutionize preclinical drug testing by developing a customizable organ-on-chip platform that mimics human multiorgan physiology, enhancing efficacy and toxicity predictions.

€ 2.496.073
EIC Pathfinder

Supervised morphogenesis in gastruloids

This project aims to develop advanced gastruloid technology to create larger, vascularized organ models that better mimic human physiology, reducing reliance on animal experiments.

€ 3.337.725
EIC Pathfinder

Next Generation 3D Tissue Models: Bio-Hybrid Hierarchical Organoid-Synthetic Tissues (Bio-HhOST) Comprised of Live and Artificial Cells.

Bio-HhOST aims to create bio-hybrid materials with living and artificial cells for dynamic communication, enhancing tissue modeling and reducing animal use in drug research.

€ 1.225.468